In this episode of All Things Chiropractic, hosts Paul Andrews and Dr. Mark Davini talk about the increasingly popular weight loss GLP-1 drugs. While initially developed to help control Type 2 diabetes, the drug’s surprising side effects have catapulted it into the limelight as a weight loss solution. However, what does this mean from a chiropractic perspective? Join Paul and Dr. Davini as they examine how GLP-1 drugs works, the physiological effects, and the potential chiropractic considerations it entails. The conversation moves from the pharmacological origins of GLP-1 to its societal implications and how it is reshaping patient care in chiropractic offices across the nation. This episode also highlights chiropractic’s role amidst these developments, probing into the new challenges chiropractors face, such as dealing with side effects often mistaken for musculoskeletal issues and the financial implications on patient care. If you’re curious about the intersection of modern pharmaceuticals and chiropractic care, and how practitioners can navigate this evolving landscape, this episode is a must-listen.